2021-11-17 | Axsome Therapeutics, Inc. AXSM | director | 3,300 0.0087% | $34.52 | $113,922 | +7% | ||
2019-05-23 | Axsome Therapeutics, Inc. AXSM | director | 3,500 0.0098% | $22.33 | $78,155 | +40.71% | ||
2012-03-14 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 10,000 0.0011% | $2.55 | $25,494 | +10.32% | ||
2011-08-12 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 6,500 0.0007% | $3.12 | $20,290 | -18.6% | ||
2010-05-21 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 6,000 0.0008% | $4.29 | $25,741 | +17.59% | ||
2008-08-12 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 15,000 0.0034% | $6.69 | $100,310 | -49.47% | ||
2006-09-05 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 1,850 0.0007% | $5.08 | $9,393 | +15.54% | ||
2006-09-01 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 1,550 0.0006% | $5.31 | $8,229 | +9.51% | ||
2006-08-31 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 750 0.0003% | $5.48 | $4,113 | +10.13% | ||
2006-08-30 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 750 0.0003% | $5.42 | $4,068 | +8.97% | ||
2006-08-29 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 800 0.0003% | $5.21 | $4,169 | +10.09% | ||
2006-08-28 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 800 0.0003% | $5.20 | $4,158 | +10.51% | ||
2006-08-25 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 800 0.0003% | $4.99 | $3,994 | +18.46% | ||
2006-08-24 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 850 0.0003% | $4.62 | $3,925 | +21.67% | ||
2006-08-23 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 850 0.0003% | $4.28 | $3,638 | +24.26% | ||
2006-08-22 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 1,617 0.0006% | $4.33 | $6,997 | +40.05% | ||
2006-08-21 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 883 0.0003% | $4.52 | $3,991 | +32.73% | ||
2004-11-18 | Plus Therapeutics, Inc. PSTV | Chief Financial Officer | 50,000 0.0224% | $3.00 | $150,000 | -3.28% |